Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 42Head & Neck 6Gynecologic 2Genitourinary 2Dermatologic 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 57Anemia, Refractory, with Excess of Blasts 48Myelodysplastic Syndromes 44Venous Thromboembolism 32Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Anemia, Aplastic 26Myeloproliferative Disorders 25Lymphoma, Non-Hodgkin 23Neoplasms 22Multiple Myeloma 21Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20Anemia 20Hodgkin Disease 19Thrombocytopenia 18Primary Myelofibrosis 18Leukemia, Myelomonocytic, Chronic 18Leukemia, Lymphocytic, Chronic, B-Cell 18Leukemia 18Hematologic Neoplasms 17Lymphoma 15Anemia, Sickle Cell 13Lymphoma, Follicular 11Fanconi Anemia 11Cytopenia 11Venous Thrombosis 10Febrile Neutropenia 10Bone Marrow Failure Disorders 10Pulmonary Embolism 9Leukemia, Biphenotypic, Acute 9Polycythemia Vera 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphedema × Classical hematology × 1 year × Clear all
NCT07612865 2026-05-29

People's Hospital of Xinjiang Uygur Autonomous Region

People's Hospital of Xinjiang Uygur Autonomous Region

Phase NA Completed
160 enrolled
Classical hematologyGynecologic

Uterine Cervical Neoplasms, Lymphedema, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡